Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,618 | 923 | 91.2% |
| Gift | $955.00 | 3 | 5.2% |
| Consulting Fee | $600.00 | 2 | 3.3% |
| Education | $39.53 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,625 | 136 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,056 | 108 | $0 (2024) |
| Novo Nordisk Inc | $1,974 | 103 | $0 (2024) |
| PFIZER INC. | $1,739 | 104 | $0 (2024) |
| Lilly USA, LLC | $1,692 | 82 | $0 (2024) |
| Sekisui Diagnostics, LLC | $955.00 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $752.18 | 44 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $731.91 | 59 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $626.82 | 41 | $0 (2024) |
| Medicure Pharma Inc. | $600.00 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,552 | 107 | Novo Nordisk Inc ($382.58) |
| 2023 | $2,141 | 97 | AbbVie Inc. ($456.12) |
| 2022 | $2,622 | 110 | ABBVIE INC. ($810.83) |
| 2021 | $1,782 | 103 | AbbVie Inc. ($589.19) |
| 2020 | $2,380 | 109 | Medicure Pharma Inc. ($600.00) |
| 2019 | $2,178 | 120 | AstraZeneca Pharmaceuticals LP ($457.58) |
| 2018 | $2,027 | 116 | PFIZER INC. ($311.09) |
| 2017 | $2,530 | 172 | AstraZeneca Pharmaceuticals LP ($301.49) |
All Payment Transactions
934 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $29.70 | General |
| Category: Narcoplepsy | ||||||
| 12/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Biological | ||||||
| 12/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: VACCINES | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Obesity | ||||||
| 10/21/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Hematology | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: PAIN | ||||||
| 10/12/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.15 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.75 | General |
| 10/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,885 | 2,495 | $281,680 | $94,216 |
| 2022 | 27 | 1,980 | 2,546 | $303,376 | $102,382 |
| 2021 | 29 | 2,405 | 3,183 | $359,912 | $127,375 |
| 2020 | 33 | 3,226 | 4,076 | $419,646 | $122,981 |
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 216 | 538 | $114,765 | $50,538 | 44.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 85 | 85 | $25,500 | $12,371 | 48.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 41 | $14,760 | $5,097 | 34.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 129 | 133 | $15,694 | $3,858 | 24.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 128 | 136 | $12,376 | $2,239 | 18.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 135 | 168 | $16,800 | $2,204 | 13.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 162 | 260 | $6,240 | $2,184 | 35.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 25 | 25 | $3,875 | $1,890 | 48.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 138 | 179 | $17,900 | $1,853 | 10.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 136 | 168 | $7,728 | $1,599 | 20.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 73 | 73 | $3,285 | $1,558 | 47.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 134 | 169 | $6,422 | $1,286 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 25 | $3,765 | $1,043 | 27.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 58 | 61 | $5,551 | $901.58 | 16.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $1,040 | $900.38 | 86.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 12 | 12 | $2,280 | $824.76 | 36.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 40 | 43 | $4,902 | $774.86 | 15.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 53 | 56 | $3,920 | $748.16 | 19.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 32 | 34 | $2,584 | $489.94 | 19.0% |
| 83550 | Iron binding capacity | Office | 2023 | 53 | 56 | $2,576 | $479.92 | 18.6% |
| 83540 | Iron level | Office | 2023 | 54 | 57 | $3,078 | $361.38 | 11.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 33 | 37 | $2,812 | $327.08 | 11.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 18 | $1,332 | $238.14 | 17.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 14 | 21 | $609.00 | $174.09 | 28.6% |
| 83735 | Magnesium level | Office | 2023 | 24 | 26 | $1,118 | $170.82 | 15.3% |
About Dr. Wayne Wu, M.D
Dr. Wayne Wu, M.D is a Internal Medicine healthcare provider based in Alexandria, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1962554436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Wu, M.D has received a total of $18,212 in payments from pharmaceutical and medical device companies, with $2,552 received in 2024. These payments were reported across 934 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($16,618).
As a Medicare-enrolled provider, Wu has provided services to 9,496 Medicare beneficiaries, totaling 12,300 services with total Medicare billing of $446,955. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Alexandria, VA
- Active Since 01/17/2007
- Last Updated 02/17/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962554436
Products in Payments
- UBRELVY (Drug) $894.83
- Ozempic (Drug) $892.83
- FARXIGA (Drug) $880.79
- VRAYLAR (Drug) $857.45
- JARDIANCE (Drug) $733.83
- XARELTO (Drug) $658.93
- HMG-CoA reductase inhibitor (Drug) $600.00
- TRULICITY (Drug) $559.13
- MOUNJARO (Drug) $549.38
- SYMBICORT (Drug) $476.06
- CHANTIX (Drug) $390.67
- QULIPTA (Drug) $360.83
- SYNTHROID (Drug) $354.77
- REXULTI (Drug) $338.94
- BREZTRI (Drug) $311.27
- JANUVIA (Drug) $298.00
- Wegovy (Drug) $277.49
- Saxenda (Drug) $277.00
- Synthroid (Drug) $272.25
- PREVNAR 20 (Biological) $238.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Alexandria
Dr. Benjamin Close, M.d, M.D
Internal Medicine — Payments: $493,843
Dr. Kanna Posina, M.d, M.D
Internal Medicine — Payments: $33,667
Robert Freedman, M.d, M.D
Internal Medicine — Payments: $18,837
Michael Mitchell, M.d, M.D
Internal Medicine — Payments: $16,622
Scott Whittaker, M.d, M.D
Internal Medicine — Payments: $16,235
Dr. Laura Robinette, Md, MD
Internal Medicine — Payments: $15,826